查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1930046

即時凝血檢測設備市場規模、佔有率、成長及全球產業分析：按類型、應用和地區劃分的洞察與預測（2025-2034）

Point-of-Care Coagulation Testing Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 請詢問到貨日

價格

即時凝血 (POCC) 偵測設備市場成長驅動因素

由於對快速、準確的凝血評估的需求日益增長，全球即時凝血 (POCC) 檢測設備市場已成為診斷技術領域的關鍵細分市場。這些設備使臨床醫生能夠即時評估患者的凝血狀態，從而支持在急診、手術和抗凝血治療監測中及時做出臨床決策。

根據這份報告，預計到2025年，全球床邊凝血檢測設備市場規模將達20.1億美元。預計到2026年，市場規模將擴大至21.6億美元，到2034年將達到38.8億美元，2026年至2034年的複合年增長率（CAGR）為7.62%。這一增長主要受出血性疾病患病率上升、床邊診斷技術進步以及家庭醫療保健解決方案日益普及的推動。

市場驅動因素與成長因素

推動市場成長的關鍵因素之一是患有出血性疾病（例如血友病、靜脈血栓栓塞和老年凝血障礙）的患者數量不斷增加。人口老化使得凝血功能失衡的風險顯著增加，從而推動了對便攜式、易用型檢測設備的需求。

此外，床邊凝血檢測（POC​​C）設備的技術進步顯著提高了檢測的準確性、易用性和出結果速度。市場參與者正在推出先進的系統，這些系統可以在醫院床邊或家庭醫療保健環境中快速提供檢測結果。隨著長期接受抗凝血治療的患者更傾向於使用可自行操作的設備以避免頻繁就醫，對家庭醫療保健解決方案的需求不斷增長，進一步加速了此類設備的普及。

另一個因素是新興市場醫療保健基礎設施的改善。這些國家的政府正在大力投資擴大診斷服務，尤其是在社區健康中心和小型診所。

市場限制因素與挑戰

儘管成長前景強勁，但市場仍面臨諸多挑戰。 POCC檢測設備的高昂成本，以及持續的維護和耗材費用，限制了其在價格敏感的新興經濟體中的普及。限制性的報銷政策和嚴格的家用檢測設備監管要求也阻礙了市場滲透。

此外，與傳統實驗室凝血檢測的競爭仍然是一大挑戰，因為傳統檢測設備憑藉其全面的檢測能力而廣受信賴。醫護人員對POCC設備的正確使用缺乏了解和訓練不足，也可能導致POCC設備的使用率低和結果誤讀。

細分市場洞察

依設備類型劃分，抗凝血監測設備將佔市場主導地位，到2026年將佔總市場佔有率的79.64%。這主要歸功於監管審批的增加以及在PT/INR水平監測中的廣泛應用。另一方面，由於黏彈性凝血監測設備能夠即時評估血栓形成的各個階段，預計在預測期內將增長最快。

依最終用戶劃分，醫院和診所預計將在2026年佔市場主導地位，市佔率達63.85%。這主要得益於需要立即進行凝血評估的複雜外科手術數量的增加。家庭醫療保健環境領域預計將以最高的複合年增長率成長，這主要歸功於患者對自我監測解決方案的偏好不斷增強。

區域展望

北美將主導全球市場，到2025年將佔8.5億美元的市場佔有率。這主要得益於主要製造商的強大影響力、出血性疾病的高發生率以及有利的監管批准。歐洲將佔第二大市場佔有率，這主要歸功於醫院對先進凝血分析儀的廣泛應用。亞太地區預計將以最高的複合年增長率成長，這主要得益於中國、印度和日本等國家日益增強的意識、監管部門的批准以及不斷擴大的醫療保健基礎設施。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇

第四章：關鍵考慮因素

  • 主要國家主要凝血障礙盛行率（2025 年）
  • 即時檢測 (POC) 凝血檢測的最新進展
  • 主要國家的監管環境
  • 主要產業發展動態：併購與合作
  • 新冠疫情對市場的影響

第五章：全球即時凝血檢測設備市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測 - 按設備類型劃分
    • 抗凝血監測設備
      • 凝血酶原時間/國際標準化比值 (PT-INR) 測量設備
      • 活化凝血時間 (ACT)
      • 活化部分凝血活酶時間 (aPTT)
    • 血小板功能監測設備
    • 黏彈性凝血監測設備
      • 血栓彈力圖 (TEG)
      • 旋轉血栓彈力圖 (ROTEM)
    • 其他
  • 市場分析、洞察與預測 - 按最終用戶劃分
    • 醫院和診所
    • 家庭醫療保健
    • 其他
  • 市場分析、洞察與預測 - 按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美即時凝血檢測設備市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲即時凝血檢測設備市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區即時凝血檢測設備市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲即時凝血檢測設備市場分析、洞察與預測（2021-2034）

  • 依國家/地區
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章 中東和非洲即時凝血檢測設備市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會國家
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • Werfen
    • CoaguSense Inc.
    • Helena Laboratories Corporation
    • Medtronic
    • Abbott
    • F.霍夫曼-拉羅氏有限公司
    • 西門子醫療保健股份公司
    • Koninklijke Philips N.V.
    • HemoSonics LLC
    • Haemonetics 公司
Product Code: FBI101235

Growth Factors of point-of-care coagulation (POCC) testing devices Market

The global point-of-care coagulation (POCC) testing devices market has emerged as a critical segment within diagnostic technologies due to the increasing need for rapid and accurate coagulation assessment. These devices enable clinicians to evaluate a patient's coagulation status in real time, supporting timely clinical decisions in emergency care, surgical procedures, and anticoagulation therapy monitoring.

According to the report, the global POCC testing devices market was valued at USD 2.01 billion in 2025. The market is projected to expand to USD 2.16 billion in 2026 and further reach USD 3.88 billion by 2034, registering a compound annual growth rate (CAGR) of 7.62% during the forecast period from 2026 to 2034. This growth is primarily driven by the rising prevalence of bleeding disorders, technological advancements in point-of-care diagnostics, and increasing adoption of home-based healthcare solutions.

Market Drivers and Growth Factors

One of the key drivers fueling market growth is the increasing patient pool suffering from bleeding disorders, including hemophilia, venous thromboembolism, and coagulation abnormalities associated with aging. The growing geriatric population is particularly vulnerable to coagulation imbalance, thereby increasing demand for portable and easy-to-use testing devices.

In addition, technological advancements in POCC testing devices have significantly improved accuracy, usability, and turnaround time. Market players are launching advanced systems capable of delivering rapid results at the bedside or in homecare settings. The rising demand for home healthcare solutions has further accelerated adoption, as patients undergoing long-term anticoagulation therapy prefer self-monitoring devices to avoid frequent hospital visits.

Another contributing factor is the improvement in healthcare infrastructure in emerging markets, where governments are investing heavily in expanding diagnostic services, especially in community healthcare centers and small clinics.

Market Restraints and Challenges

Despite strong growth prospects, the market faces notable challenges. The high cost of POCC testing devices, along with recurring expenses related to maintenance and consumables, restricts adoption in price-sensitive and emerging economies. Limited reimbursement policies and stringent regulatory requirements for home-based testing devices also hinder market penetration.

Furthermore, competition from traditional laboratory coagulation testing remains a challenge, as conventional analyzers are widely trusted for their comprehensive testing capabilities. A lack of awareness and insufficient training among healthcare professionals regarding the correct use of POCC devices can also lead to underutilization and misinterpretation of results.

Segmentation Insights

By device type, anticoagulation monitoring devices dominated the market, accounting for 79.64% of the total market share in 2026, supported by increasing regulatory approvals and widespread use in monitoring PT/INR levels. Meanwhile, viscoelastic coagulation monitoring devices are expected to witness the fastest growth during the forecast period due to their ability to assess all stages of clot formation in real time.

By end user, the hospitals and clinics segment led the market with a 63.85% share in 2026, driven by the growing number of complex surgical procedures requiring immediate coagulation assessment. The homecare settings segment is anticipated to grow at the highest CAGR due to rising patient preference for self-monitoring solutions.

Regional Outlook

North America dominated the global market in 2025, accounting for USD 0.85 billion, supported by the strong presence of leading manufacturers, high prevalence of bleeding disorders, and favorable regulatory approvals. Europe held the second-largest share due to the introduction of advanced coagulation analyzers in hospitals. The Asia Pacific region is expected to grow at the highest CAGR, driven by increasing awareness, regulatory approvals, and expanding healthcare infrastructure in countries such as China, India, and Japan.

Competitive Landscape

The market is semi-consolidated, with major players including F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers AG, Werfen, Haemonetics Corporation, and Medtronic. These companies focus on strategic collaborations, regulatory approvals, and product innovations to strengthen their market position.

Conclusion

In conclusion, the global point-of-care coagulation (POCC) testing devices market is poised for sustained growth, rising from USD 2.01 billion in 2025 to USD 3.88 billion by 2034. The increasing burden of bleeding disorders, growing demand for rapid diagnostic solutions, and expansion of home-based healthcare are key factors shaping market expansion. While high costs and competition from traditional laboratory testing pose challenges, ongoing technological advancements and strategic initiatives by leading players are expected to enhance adoption and drive long-term market growth across developed and emerging regions.

Growth rate CAGR of 7.62% from 2026-2034

Segmentation

By Device Type

  • Anticoagulation Monitoring Devices
  • Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices
  • Activated Clotting Time (ACT)
  • Activated Partial Thromboplastin Time (aPTT)
  • Platelet Function Monitoring Devices
  • Viscoelastic Coagulation Monitoring Devices
  • Thromboelastography (TEG)
  • Rotational Thromboelastometry (ROTEM)
  • Others

By End User

  • Hospitals & Clinics
  • Homecare Settings
  • Others

By Region

  • North America (by Device Type, by End User, by Country)
    • U.S.
    • Canada
  • Europe (by Device Type, by End User, by Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (by Device Type, by End User, by Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Latin America (by Device Type, by End User, by Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (by Device Type, by End User, by Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Prevalence of Key Coagulation Diseases- For Key Countries, 2025
  • 4.2. Recent Advancements in the Point of Care (POC) Coagulation Testing
  • 4.3. Regulatory Scenario - For Key Countries
  • 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.5. Impact of COVID-19 on the Market

5. Global Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Device Type
    • 5.1.1. Anticoagulation Monitoring Devices
      • 5.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 5.1.1.2. Activated Clotting Time (ACT)
      • 5.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 5.1.2. Platelet Function Monitoring Devices
    • 5.1.3. Viscoelastic Coagulation Monitoring Devices
      • 5.1.3.1. Thromboelastography (TEG)
      • 5.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By End User
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Homecare
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Device Type
    • 6.1.1. Anticoagulation Monitoring Devices
      • 6.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 6.1.1.2. Activated Clotting Time (ACT)
      • 6.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 6.1.2. Platelet Function Monitoring Devices
    • 6.1.3. Viscoelastic Coagulation Monitoring Devices
      • 6.1.3.1. Thromboelastography (TEG)
      • 6.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By End User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Homecare
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Device Type
    • 7.1.1. Anticoagulation Monitoring Devices
      • 7.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 7.1.1.2. Activated Clotting Time (ACT)
      • 7.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 7.1.2. Platelet Function Monitoring Devices
    • 7.1.3. Viscoelastic Coagulation Monitoring Devices
      • 7.1.3.1. Thromboelastography (TEG)
      • 7.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By End User
    • 7.2.1. Hospitals & Clinics
    • 7.2.2. Homecare
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia Pacific Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Device Type
    • 8.1.1. Anticoagulation Monitoring Devices
      • 8.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 8.1.1.2. Activated Clotting Time (ACT)
      • 8.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 8.1.2. Platelet Function Monitoring Devices
    • 8.1.3. Viscoelastic Coagulation Monitoring Devices
      • 8.1.3.1. Thromboelastography (TEG)
      • 8.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By End User
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Homecare
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Device Type
    • 9.1.1. Anticoagulation Monitoring Devices
      • 9.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 9.1.1.2. Activated Clotting Time (ACT)
      • 9.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 9.1.2. Platelet Function Monitoring Devices
    • 9.1.3. Viscoelastic Coagulation Monitoring Devices
      • 9.1.3.1. Thromboelastography (TEG)
      • 9.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By End User
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Homecare
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Device Type
    • 10.1.1. Anticoagulation Monitoring Devices
      • 10.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 10.1.1.2. Activated Clotting Time (ACT)
      • 10.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 10.1.2. Platelet Function Monitoring Devices
    • 10.1.3. Viscoelastic Coagulation Monitoring Devices
      • 10.1.3.1. Thromboelastography (TEG)
      • 10.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By End User
    • 10.2.1. Hospitals & Clinics
    • 10.2.2. Homecare
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. GCC Countries
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Werfen
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. CoaguSense Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Helena Laboratories Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Medtronic
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Abbott
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. F. Hoffmann-La Roche Ltd
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Siemens Healthcare AG
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Koninklijke Philips N.V.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. HemoSonics LLC
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Haemonetics Corporation
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 2: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 3: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 4: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 7: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 8: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 9: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 12: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 13: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 14: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 15: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 17: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 18: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 19: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 22: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 23: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 24: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 27: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 28: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 29: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2025 & 2034
  • Figure 3: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2025 & 2034
  • Figure 4: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 6: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 7: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 8: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 9: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country, 2023
  • Figure 11: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 12: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 13: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 15: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
  • Figure 17: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 18: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 19: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 20: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 21: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
  • Figure 23: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 24: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 25: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 26: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 27: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
  • Figure 29: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 30: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 31: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 32: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 33: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
  • Figure 35: Global Point-of-Care Coagulation (POCC) Testing Devices Market Share (%), By Company, 2023